Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PCK2 |
| Upstream (Parents) |
|---|
| (<<) HMGCL → PCK2 |
| (<<) DCXR → PCK2 |
| (<<) PXMP2 → PCK2 |
| Downstream (Children) |
|---|
| PCK2 → LGSN (>>) |
| PCK2 → GSTA3 (>>) |
| PCK2 → NRTN (>>) |
| PCK2 → CYP1A1 (>>) |
| PCK2 → SULT1E1 (>>) |
| PCK2 → TMEM158 (>>) |
| PCK2 → CYP2B7P1 (>>) |
| PCK2 → CNIH3 (>>) |
| PCK2 → PSAT1 (>>) |
| PCK2 → GSTZ1 (>>) |
| PCK2 → MLXIPL (>>) |
| PCK2 → GALNT10 (>>) |
| PCK2 → TM7SF2 (>>) |
| PCK2 → RHBG (>>) |
| PCK2 → INSIG1 (>>) |
| PCK2 → NAAA (>>) |
| PCK2 → PHGDH (>>) |
| PCK2 → DAK (>>) |
| PCK2 → AK3L2///AK4 (>>) |
| PCK2 → CBR1 (>>) |
| PCK2 → SLC43A1 (>>) |
| PCK2 → FANCC (>>) |
